Patient Care

MDNA Life Sciences, Inc.

OPTIMI HEALTH CORP

HCW Biologics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

GCL Global

Micware

Silexion Therapeutics

MicroAlgo

MetaVia

BiomX

Vida Global

NDRA

OLSI

MDLS

Denver Life Sciences announced that serial entrepreneur Mike Iiams has invested in the company and joined its board. DLS aims to address chronic dehydration, a health risk affecting 72 million Americans annually, by using advanced sensors to measure hydration levels in under 45 seconds. The company offers a modern alternative to outdated hydration measurement methods, providing personalized insights through a mobile app. Iiams, motivated by personal experiences, sees DLS's mission and technology as a significant advancement in health and wellness.

prnewswire

Endra Life Sciences

Origin Life Sciences

SPDR S&P Biotech

SPDR S&P Health Equip

ALPS Medical Breakthrough

VanEck Biotech ETF

First Trust NYSE Arca Biotech Index Fd

iShares Biotechnology ETF

Direxion S&P Biotech Bull 3X

iShares US Medical Devices

Proshares Ultra Nasdaq Biotech

Invesco Biotechnology & Genome ETF

11:09 ETSerial Entrepreneur Invests in Hydration Mission

Discovery Life Sciences and Mindpeak have formed a partnership to enhance cancer biomarker testing in global clinical trials using AI. This collaboration aims to address the inconsistent interpretation of biomarkers by pathologists, which has been a significant challenge in drug development. By integrating AI-driven digital image analysis into immunohistochemistry (IHC) and multiplex immunofluorescence (mIF) services, the partnership seeks to improve biomarker quantification and consistency, thereby reducing variability and increasing confidence in critical development decisions. The partnership will be showcased at the AACR 2026 annual meeting.

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

Tiziana Life Sciences

iShares US Pharma

VG Health

Invesco Nasdaq Biotechnology ETF

iShares Global Healthcare

12:05 ETPartnerství společností Discovery Life Sciences a Mindpeak vnáší přesnost AI do testování biomarkerů rakoviny v globálních klinických studiích

MDA SPACE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING IN THE UNITED STATES | MDA Stock News

StockTitan

MDA Space

MDA SPACE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING IN THE UNITED STATES | MDA Stock News

IDNA

Notice of Pendency and Proposed Settlement of Stockholder Class Action for CM Life Sciences III, Inc. Class A Common Stock. A settlement of $7,250,000 has been proposed, affecting all record and beneficial holders of the stock as of December 14, 2021. A hearing is scheduled for April 21, 2026, to determine the approval of the settlement and related matters. Class members must submit a Proof of Claim to participate in the distribution of the settlement fund.

iShares Genomics Immunology and Healthcare ETF

Caris Life Sciences

09:13 ETNotice of Pendency and Proposed Settlement of Stockholder Class Action Involving All Record and Beneficial Holders of CM Life Sciences III, Inc. Class A Common Stock on December 14, 2021

CS精准医

VOYG

NNNN

Starlab Space LLC has partnered with Auxilium Biotechnologies to enhance life sciences research in microgravity. Auxilium will provide 3D bioprinting and biofabrication capabilities aboard the Starlab space station, focusing on regenerative medicine and tissue engineering. This collaboration aims to accelerate the development of implantable medical devices and complex tissue structures, leveraging microgravity for breakthroughs in medical technology. Starlab's infrastructure will support advanced research and manufacturing, ultimately benefiting both space missions and healthcare on Earth.

Voyager Tech

Anbio Biotechnology

Hwabao WP CSI Pharmaceuticals ETF

China Universal CNI HK Connect Innovative Drugs Industry ETF

Bosera Hang Seng SCHK Innovative Drug Select ETF

Huatai-PB Hang Seng Innovative Drugs Industry ETF(QDII)

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

Guotai CSI Bio-medicine ETF

Bosera Hang Seng Health Care ETF(QDII)

Hwabao WP CSI Medical Service ETF

ChinaAMC CSI Biotechnology Theme ETF

Starlab Space and Auxilium Biotechnologies to Advance Life Sciences Research in Microgravity | VOYG Stock News

StageZero Life Sciences, Ltd. announced a Partial Revocation Order from the Ontario Securities Commission, allowing the company to conduct a private placement financing of up to $2.5 million through secured convertible debentures. The financing aims to resolve outstanding fees and prepare audited financial statements while the failure-to-file cease trade order remains in effect. The company plans to apply for a full revocation of the cease trade order after the financing. The private placement is subject to NEX approval and will be offered to accredited investors in Ontario, British Columbia, and Alberta.

The newswire.ca

StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing

MDNA Life Sciences, Inc.(MDLS.US)

11:09 ETSerial Entrepreneur Invests in Hydration Mission

12:05 ETPartnerství společností Discovery Life Sciences a Mindpeak vnáší přesnost AI do testování biomarkerů rakoviny v globálních klinických studiích

MDA SPACE ANNOUNCES CLOSING OF INITIAL PUBLIC OFFERING IN THE UNITED STATES | MDA Stock News

09:13 ETNotice of Pendency and Proposed Settlement of Stockholder Class Action Involving All Record and Beneficial Holders of CM Life Sciences III, Inc. Class A Common Stock on December 14, 2021

Starlab Space and Auxilium Biotechnologies to Advance Life Sciences Research in Microgravity | VOYG Stock News

StageZero Announces Partial Revocation of Failure to File Cease Trade Order and Proposed Financing